Highlights
- •The use of technologic innovation (eg. antimicrobial catheters) to prevent HAIs is widespread.
- •Both larger and smaller hospitals have adopted technologic approaches to HAI prevention.
- •Although the recent decrease in CLABSI is largely attributed to practice changes (checklist/insertion bundle), widespread technologic interventions may have also played a role.
- •Almost all hospitals have some form of antimicrobial stewardship.
An array of devices and products designed to prevent health care-associated infections
are commercially available. Data indicating device efficacy are often mixed and frequency
of product use is largely unknown. This statewide assessment was performed to determine
hospital use of infection prevention products and to examine differences between larger
and smaller hospitals.
Key Words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of Infection ControlAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Multistate point prevalence survey of healthcare-associated infections.N Engl J Med. 2014; 370: 1198-1208
- Centers for Disease Control and Prevention.(Antibiotic resistance threats in the United States; Available from:) (Accessed January 24, 2015)
- Is the use of antimicrobial devices to prevent infection correlated across different healthcare-associated infections? Results from a national survey.Infect Control Hosp Epidemiol. 2013; 34: 847-849
- Centers for Disease Control and Prevention.(National and state healthcare associated infections progress report; Available from:) (Accessed January 24, 2015)
Article info
Publication history
Published online: June 15, 2016
Footnotes
This work was presented in abstract form at the 41st Annual Meeting of the Association for Professionals in Infection Control and Epidemiology, Inc, Anaheim, CA, June 8-10, 2014.
Conflicts of Interest: MER receives research contract support from 3M, Magnolia, and the National Institutes of Health and serves as a paid consultant for 3M and Sharklet. PL serves as a paid consultant for Nobel Biomaterials, Inc.
Identification
Copyright
© 2016 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
